Loading the map…

None Supplied · Minato-Ku, Tokyo 107-0052

Nxera Pharma Co

Nxera Pharma Co., Ltd.

ActiveAs filed (group accounts)24 years on the register

Other company type registered in Minato-Ku, classed under “None Supplied”.

Headline figures

No figures yet.

This company's accounts are on file with Companies House, but we haven't extracted them yet. Once we do, its net assets, cash, reserves and any disclosed profit will appear here.

Timeline

Checked 2026-10-30

  1. Directors
    Termination of appointment of Shinichi Tamura as a director on 26 March 2025
  2. Directors
    Termination of appointment of Miwa Seki as a director on 25 March 2026
  3. Directors
    Termination of appointment of Noriaki Nagai as a director on 25 March 2026
  4. Directors
    Termination of appointment of Kuniaki Kaga as a director on 26 March 2025
  5. Directors
    Termination of appointment of Tomohiro Tohyama as a director on 26 March 2025
  6. Accounts
    Group of companies' accounts made up to 31 December 2023
  7. Name
    Change of registered name of an overseas company on 4 April 2024 from Sosei group corporation
  8. Filing
    Details changed for a UK establishment - BR006736 Name Change (and 3 more like it since 17 January 2012)
  9. Filing
    Details changed for an overseas company (and 2 more like it since 26 March 2010)
  10. Accounts
    Group of companies' accounts made up to 31 December 2021
  11. Accounts
    Group of companies' accounts made up to 31 December 2022
  12. Filing
    Details changed for an overseas company (and 13 more like it since 22 July 2015)
  13. 28 earlier
    1. Directors
      Appointment of Miwa Seki as a director on 24 March 2022
    2. Directors
      Appointment of Eiko Tomita as a director on 1 April 2023
    3. Directors
      Appointment of Christopher Cargill as a director on 24 March 2022
    4. Directors
      Appointment of Christopher Cargill as a person authorised to represent UK establishment BR006736 on 17 August 2021
    5. Accounts
      Group of companies' accounts made up to 31 December 2020
    6. Accounts
      Group of companies' accounts made up to 31 December 2019
    7. Directors
      Appointment of Mr Rolf-Kristian Soderstrom as a director on 25 March 2020
    8. Directors
      Termination of appointment of Julia Paige Gregory as a director on 25 March 2020
    9. Accounts
      Full accounts made up to 31 March 2018
    10. Accounts
      Full accounts made up to 31 March 2017
    11. Accounts
      Full accounts made up to 31 December 2018
    12. Directors
      Appointment of Julia Gregory as a director on 22 June 2017
    13. Directors
      Appointment of Doctor David Roblin as a director on 22 June 2018
    14. Directors
      Appointment of Mr Noriaki Nagai as a director on 27 March 2019
    15. Directors
      Appointment of Mr Kuniaki Kaga as a director on 22 June 2018
    16. Directors
      Director's details changed for Mr Shinichi Tamura on 18 June 2018
    17. Directors
      Termination of appointment of Takuya Fujii as a director on 22 June 2018
    18. Directors
      Termination of appointment of Declan Doogan as a director on 22 June 2018
    19. Directors
      Termination of appointment of Peter James Jonathan Bains as a director on 31 December 2018
    20. Accounts
      Full accounts made up to 31 March 2016
    21. Filing
      Alteration of constitutional documents on 20 June 2013
    22. Accounts
      Full accounts made up to 31 March 2015
    23. Accounts
      Full accounts made up to 31 March 2014
    24. Directors
      Appointment of Peter James Jonathan Bains as a director on 22 June 2010
    25. Accounts
      Full accounts made up to 31 March 2013
    26. Accounts
      Full accounts made up to 31 March 2012
    27. Accounts
      Full accounts made up to 31 March 2011
    28. Directors
      Termination of appointment of Isao Muramatsu as a director

From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.

Questions people ask

›What does Nxera Pharma Co do?

Other company type registered in Minato-Ku, classed under “None Supplied”.

›How much turnover does Nxera Pharma Co make?

Answered in the full report

›Is Nxera Pharma Co profitable?

Nxera Pharma Co's profit isn't public: small companies may file without a profit and loss account.

›Who runs and owns Nxera Pharma Co?

Its directors are Christopher Cargill, David Doctor Roblin, Rolf-Kristian Soderstrom, Eiko Tomita. Its owners are shown to subscribers.

›Where is Nxera Pharma Co based?

Its registered office is Midtown East 7f, 9-7-2 Akasaka, Minato-Ku, TOKYO 107-0052, in Minato-Ku, Tokyo 107-0052.

›When was Nxera Pharma Co founded?

Nxera Pharma Co., Ltd. was incorporated on 1 April 2002.

›Is Nxera Pharma Co still trading?

The register lists Nxera Pharma Co., Ltd. as active.